In patients with AD [8–13] and several transgenic mouse models of Aβ amyloidosis and tau accumulation, differences in gut microbiota composition compared with controls, have been documented indicating a connection between gut microbiota and Alzheimer’s pathophysiology [14–18]. This evidence concerns the gene MAPT and Alzheimer disease.